Printer Friendly

Research and Markets: Global Acute Myeloid Leukemia Epidemiology and Patient Flow Analysis - 2012.

DUBLIN -- Research and Markets (http://www.researchandmarkets.com/research/v48xh4/global_acute) has announced the addition of the "Global Acute Myeloid Leukemia Epidemiology and Patient Flow Analysis - 2012" report to their offering.

The report provides insights into Acute Myeloid Leukemia epidemiology, Acute Myeloid Leukemia diagnosed patients, and Acute Myeloid Leukemia treatment rate for top seven pharmaceutical markets. The study measures key indicators such as prevalence of Acute Myeloid Leukemia derived from epidemiological analysis, percentage of patients diagnosed with Acute Myeloid Leukemia, and percentage of patients treated with Acute Myeloid Leukemia therapy.

The study helps executives estimate Acute Myeloid Leukemia market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The report provides estimates and forecasts of Acute Myeloid Leukemia prevalence, Acute Myeloid Leukemia diagnosis rate, and Acute Myeloid Leukemia treatment rate for the period 2012-2019. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan. The study design is based on collection and interpretation of data from registries, scientific journals and literatures, government databases and other secondary sources.

Key Features of the Report:

- Acute Myeloid Leukemia: Disease Definition

- Acute Myeloid Leukemia Patient Flow

- Acute Myeloid Leukemia Prevalence

- Acute Myeloid Leukemia Diagnosed Patients

- Acute Myeloid Leukemia Treated Patients

For more information visit http://www.researchandmarkets.com/research/v48xh4/global_acute
COPYRIGHT 2012 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2012 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Nov 16, 2012
Words:290
Previous Article:Research and Markets: Global Sickle Cell Anaemia Drug Pipeline Capsule - 2012 Update.
Next Article:Research and Markets: Global Age-Related Macular Degeneration Epidemiology and Patient Flow Analysis - 2012.
Topics:

Terms of use | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters